| | Title | Authors / Editors | Date |
|
unige:90934 |
Functional imaging markers of the MCI brain in task and at rest: detecting memory and connectivity impairments in prodromal Alzheimer's disease |
Kebets, Valeria |
2016 |
|
unige:83554 |
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study' |
PharmaCog Consortium |
2016 |
|
unige:93779 |
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study |
Mauthner, Oliver; Claes, Veerle; Walston, Jeremy; Engberg, Sandra; ... De Geest, Sabina |
2017 |
|
unige:100349 |
Contribution of electro-cortical imaging to neuroscience of aging and cognitive decline |
Deiber Ibanez, Marie-Pierre |
2017 |
|
unige:128625 |
Multivariate and predictive modelling of neural variability in mild cognitive impairment |
Kebets, Valeria; Van Assche, Mitsouko; Richiardi, Jonas; Goldstein, Rachel; ... Van De Ville, Dimitri |
2018 |
|
unige:116120 |
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease |
Collaboration |
2018 |
|
unige:114054 |
AMYPAD Diagnostic and Patient Management Study: Rationale and design |
Frisoni, Giovanni; Barkhof, Frederik; Canzoneri, Elisa |
2018 |
|
unige:140370 |
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease |
Marizzoni, Moira; Ferrari, Clarissa; Macis, Ambra; Jovicich, Jorge; ... Frisoni, Giovanni |
2019 |
|
unige:127233 |
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features |
Low, Audrey; Mak, Elijah; Malpetti, Maura; Chouliaras, Leonidas; ... O'Brien, John T. |
2019 |
|
unige:116115 |
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers |
The PharmaCog Consortium |
2019 |
|
unige:140839 |
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status |
Marizzoni, Moira; Ferrari, Clarissa; Babiloni, Claudio; Albani, Diego; ... Frisoni, Giovanni |
2020 |
|
unige:132778 |
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease |
Ramusino, Matteo Cotta; Garibotto, Valentina; Bacchin, Ruggero; Altomare, Daniele; ... Frisoni, Giovanni |
2020 |
Mild cognitive impairment
add all
remove all
